000 04748nam a22005895i 4500
001 978-981-99-9195-2
003 DE-He213
005 20251030112026.0
007 cr nn 008mamaa
008 240502s2024 si | s |||| 0|eng d
020 _a9789819991952
_9978-981-99-9195-2
024 7 _a10.1007/978-981-99-9195-2
_2doi
050 4 _aQR355-502
072 7 _aPSGL
_2bicssc
072 7 _aSCI099000
_2bisacsh
072 7 _aPSG
_2thema
245 1 0 _aAdvances in Antiviral Research
_h[electronic resource] /
_cedited by Naveen Kumar, Yashpal Singh Malik, Shailly Tomar, Sayeh Ezzikouri.
250 _a1st ed. 2024.
264 1 _aSingapore :
_bSpringer Nature Singapore :
_bImprint: Springer,
_c2024.
300 _aXIX, 453 p. 1 illus.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aLivestock Diseases and Management,
_x2662-4354
505 0 _a1. Antivirals: approaches and the way forward -- 2. Bioinformatics databases and tools available for the development of antiviral drugs -- 3. Developments in computer-aided drug design for antiviral research -- 4. Organoids in antiviral research: potential and challenges -- 5. Metabolomics tools in antiviral research -- 6. Epigenetic- and epitranscriptomic- targeted reprogramming: novel targets for the development of broad-spectrum antivirals -- 7. Application of cryoelectron microscopy in antiviral research -- 8. Host directed antiviral therapy -- 9. Role of herbal formulations in antiviral therapy - an overview -- 10. The use of animal models for antiviral therapeutics development: opportunities and challenges -- 11. In-vitro and in-vivo evaluation tools of SARS-CoV-2 antiviral drugs -- 12. Discovery of SARS-CoV-2 antiviral drugs through large-scale virtual screening of FDA-approved drugs -- 13. A high-throughput computational pipeline for selection of effective antibody therapeutics against viruses -- 14. Insights on various antiviral drugs for treating patients with COVID- 19 -- 15. In ovo based antiviral assay for screening of herbal formulations against Influenza viruses -- 16. The path to cure Hepatitis B: How far are we? -- 17. Unveiling emerging avenues in antiviral research: navigating clinical trials and regulatory landscapes.
520 _aThis book illustrates advancements in the sophisticated tools and techniques for discovering and designing new antiviral drugs, identifying approved drugs against new and emerging viruses through large-scale computational virtual screening or drug repurposing approaches, and their evaluation in various in vitro and in vivo models. The chapters also cover the challenges associated with the emergence of antiviral drug resistance and possible ways to counter them. It discusses bioinformatics tools and software and computational approaches for the discovery of antivirals. The books also outline approaches for designing broad-spectrum antivirals effective against viruses by epigenetic- and epitranscriptomic-targeted reprogramming. Further, it provides vital details on the procedures for drug applications, clinical trials, and their regulations. Finally, the book provides a comprehensive yet representative description of advances in antiviral research protocols and methodologies suitable for antiviral researchers at all career stages, including graduate and postgraduate students and policy-makers.
650 0 _aVirology.
_972539
650 0 _aDrugs
_xDesign.
_964861
650 0 _aBioinformatics.
_964050
650 1 4 _aVirology.
_972539
650 2 4 _aStructure-Based Drug Design.
_971118
650 2 4 _aBioinformatics.
_964050
700 1 _aKumar, Naveen.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_976290
700 1 _aMalik, Yashpal Singh.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_972014
700 1 _aTomar, Shailly.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_976291
700 1 _aEzzikouri, Sayeh.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_976292
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9789819991945
776 0 8 _iPrinted edition:
_z9789819991969
776 0 8 _iPrinted edition:
_z9789819991976
830 0 _aLivestock Diseases and Management,
_x2662-4354
_976293
856 4 0 _uhttps://doi.org/10.1007/978-981-99-9195-2
912 _aZDB-2-SBL
912 _aZDB-2-SXB
999 _c59616
_d59616